Corey Keith Goldman

Title: Corey Keith Goldman: Innovator in Chronic Kidney and Coronary Artery Disease Detection

Introduction: Corey Keith Goldman, located in Metairie, Louisiana, is a notable inventor known for his contributions in medical diagnostics. With a focus on chronic kidney disease (CKD) and coronary artery disease (CAD), Goldman has been instrumental in developing innovative detection methods that aid in the early diagnosis of these conditions.

Latest Patents: Corey Keith Goldman holds two significant patents, both centered around the detection of chronic kidney disease and coronary artery disease through the use of bone morphogenic protein-4 (BMP-4). The inventions outline a method for detecting CAD in patients diagnosed with CKD and vice versa. By assaying plasma or serum samples for elevated levels of BMP-4, these innovations provide medical professionals with critical information to better manage patient care.

Career Highlights: Goldman is affiliated with the Ochsner Clinic Foundation, where his work emphasizes the importance of advancing diagnostic techniques in the medical field. His innovative spirit and dedication to healthcare have made a profound impact on patient diagnostics.

Collaborations: Working alongside his coworker, Thomas Cooper Woods, Goldman has fostered a collaborative environment that thrives on innovation. Their combined efforts have contributed significantly to the ongoing advancements in medical detection technologies.

Conclusion: Corey Keith Goldman exemplifies the role of an inventor dedicated to improving health outcomes through innovative solutions. His patents reflect a commitment to developing effective diagnostic methods, proving that innovation in medicine can transform patient care and lead to better health management.